|
|
- CAS号:
- 1627091-47-7
- 英文名:
- MLi-2
- 英文别名:
- MLi-2;MLi2,MLi-2,Inhibitor,Leucine-rich repeat kinase 2,inhibit,disease,orally,LRRK2,Parkinson’s,MLi 2;rel-(2S,6R)-2,6-Dimethyl-4-(6-(5-(1-methylcyclopropoxy)-1H-indazol-3-yl)pyrimidin-4-yl)morpholine;rel-3-[6-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-4-pyrimidyl]-5-[(1-methylcyclopropyl)oxy]-1H-indazole;1H-Indazole, 3-[6-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-4-pyrimidinyl]-5-[(1-methylcyclopropyl)oxy]-, rel-
- 中文名:
- REL-3-[6-[(2R,6S)-2,6-二甲基-4-吗啉基]-4-嘧啶基]-5-[(1-甲基环丙基)氧基]-1H-吲唑
- 中文别名:
- 化合物MLI-2;MLI-2,LRRK2抑制剂;REL-(2R,6S)-2,6-二甲基-4-(6-(5-(1-甲基环丙氧基)-1H-吲唑-3-基)嘧啶-4-基)吗啉;REL-3-[6-[(2R,6S)-2,6-二甲基-4-吗啉基]-4-嘧啶基]-5-[(1-甲基环丙基)氧基]-1H-吲唑
- CBNumber:
- CB83167643
- 分子式:
- C21H25N5O2
- 分子量:
- 379.46
- MOL File:
- 1627091-47-7.mol
|